Increased periocular pigmentation with ocular hypotensive lipid use in African Americans

American Journal of Ophthalmology

Volumn 135, Issue 5, 2003, Pages 713-715

  Herndon, Leon W ^a   Williams, Robert D ^b   Wand, Martin ^c   Asrani, Sanjay ^a  

^a DUKE UNIVERSITY EYE CENTER   (United States)

^b Taustine Eye Center   (United States)

^c Consulting Ophthalmologists ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIMATOPROST; BRIMONIDINE; LATANOPROST; LIPID;

ADULT; AFRICA; ARTICLE; CASE REPORT; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG TOLERANCE; DRUG WITHDRAWAL; EYELASH; EYELID; FEMALE; GOOD GENERAL CONDITION; HUMAN; HYPERPIGMENTATION; INTRAOCULAR HYPOTENSION; OPEN ANGLE GLAUCOMA; PIGMENT EPITHELIUM; PRIORITY JOURNAL; WESTERN HEMISPHERE;

EID: 0345352731     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(02)02146-3     Document Type: Article

References (5)

1. Alm A., Stjernschantz J. Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. Ophthalmology. 102:1995;1743-1752.
2. Kook M.S., Lee K. Increased eyelid pigmentation associated with use of latanoprost. Am J Ophthalmol. 129:2000;804-806.
3. Wand M., Ritch R., Isbey E., et al. Latanoprost and periocular skin color changes. Arch Ophthalmol. 119:2001;614-615.
4. Johnstone M.A. Hypertrichiasis and increased pigmentation of eyelashes and adjacent hair in the region of the ipsilateral eyelids of patients treated with unilateral topical latanoprost. Am J Ophthalmol. 124:1997;544-547.
5. Brandt J.D., VanDenburgh A.M., Chen K., et al. Comparison of once- or twice-daily bimatoprost with twice-daily timolol in patients with elevated intraocular pressure a 3-month clinical trial. Ophthalmology. 108:2001;1023-1031.